Literature DB >> 17068702

Bone remodeling around the Cambridge cup: a DEXA study of 50 hips over 2 years.

Richard E Field1, Michael D Cronin, Parminder J Singh, Christine Burtenshaw, Neil Rushton.   

Abstract

BACKGROUND: In a prospective 2-year study we have used dual-energy X-ray absorptiometry to measure periprosthetic bone mineral density (BMD) following implantation of a novel, "physiological", acetabular component designed using composite materials.
METHOD: The acetabular components were implanted in hydroxyapatite (HA) and HA-removed options. They were implanted in conjunction with a cemented femoral component in 50 female patients who presented with displaced, subcapital, fractures of the neck of the femur. Regions of interest (ROI) were defined according to De Lee and Charnley. BMD during follow-up was compared with immediate postoperative values for the affected limb.
RESULTS: The mean precision error (CV%) was 1.01%, 2.26% and 1.12%, for ROI I, II and III respectively. The mean change in BMD, for both cups, was analyzed. There was no significant difference between the BMD changes induced with the HA- and non-HA-coated cups.
INTERPRETATION: After an initial fall in BMD in all 3 ROI at 6 months, ROI I and ROI II showed return to baseline BMD by 2 years. ROI III showed no significant decrease in BMD beyond 6 months, but did not return to baseline levels. Statistical analysis revealed no significant decrease in BMD in ROI I and ROI II at 2 years, compared with immediate postoperative values. The changes in BMD reflect a pattern of maximally reduced stress in the non-weight-bearing zone (ROI III), with preservation of bone density in weight bearing zones ROI I and ROI II. These results support the design principles of the Cambridge cup.

Entities:  

Mesh:

Year:  2006        PMID: 17068702     DOI: 10.1080/17453670610012908

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  8 in total

1.  Pre-clinical studies to validate the MITCH PCR Cup: a flexible and anatomically shaped acetabular component with novel bearing characteristics.

Authors:  Ahmed M H Latif; Aude Mehats; Martyn Elcocks; Neil Rushton; Richard E Field; Eric Jones
Journal:  J Mater Sci Mater Med       Date:  2007-11-08       Impact factor: 3.896

2.  Abnormal subchondral bone microstructure following steroid administration is involved in the early pathogenesis of steroid-induced osteonecrosis.

Authors:  L Wang; L Zhang; H Pan; S Peng; X Zhao; W W Lu
Journal:  Osteoporos Int       Date:  2015-07-09       Impact factor: 4.507

Review 3.  New alternate bearing surfaces in total hip arthroplasty: A review of the current literature.

Authors:  Preston W Grieco; Scott Pascal; Jared M Newman; Neil V Shah; Sarah G Stroud; Neil P Sheth; Aditya V Maheshwari
Journal:  J Clin Orthop Trauma       Date:  2017-10-27

Review 4.  Bearing surfaces in hip replacement - Evolution and likely future.

Authors:  Narinder Kumar; Gen N C Arora; Barun Datta
Journal:  Med J Armed Forces India       Date:  2014-08-04

Review 5.  PEEK biomaterials in trauma, orthopedic, and spinal implants.

Authors:  Steven M Kurtz; John N Devine
Journal:  Biomaterials       Date:  2007-08-07       Impact factor: 12.479

6.  Increased risk of revision of acetabular cups coated with hydroxyapatite.

Authors:  Stergios Lazarinis; Johan Kärrholm; Nils P Hailer
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

7.  Reverse hybrid and cemented hip replacement compared using radiostereometry and dual-energy X-ray absorptiometry: 43 hips followed for 2 years in a prospective trial.

Authors:  Einar Lindalen; Jon Dahl; Lars Nordsletten; Finnur Snorrason; Øystein Høvik; Stephan Röhrl
Journal:  Acta Orthop       Date:  2012-11-01       Impact factor: 3.717

8.  Cancellous and cortical bone mineral density around an elastic press-fit socket in total hip arthroplasty.

Authors:  Dean F M Pakvis; Petra J C Heesterbeek; Marianne Severens; Maarten Spruit
Journal:  Acta Orthop       Date:  2016-09-23       Impact factor: 3.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.